Anterix (ATEX) stock is in focus after the company reported first quarter 2026 results, with sales of US$1.96 million and net income of US$0.24 million for the period ended June 30. See our latest analysis for Anterix. The latest quarter has landed while Anterix’s share price has eased 13% over the past month. It remains sharply higher, with a 90 day share price return of 47.8% and a very large year to date gain of 298.92%, alongside a 1 year total shareholder return of 317.71% and 3 year...

Bandwidth and Anterix stand to benefit from fiber, 5G, IoT and cloud trends as communication infrastructure demand expands.

Revenue grew to $2 million as spectrum monetization opportunities expand.

The infrastructure upgrade for digital transformation, fiber densification and 5G rollout should help the Zacks Communication - Infrastructure industry thrive despite short-term headwinds. BAND and ATEX are likely to benefit from the continued transition to cloud networks.

Anterix (NASDAQ:ATEX) executives said the company sees growing demand and limited supply for its low-band 900 MHz spectrum, citing recent spectrum transactions and potential satellite-direct-to-device applications as factors that could expand monetization options beyond its traditional utility custo

ATEX highlights rising licensed low-band spectrum demand, accelerating strategic interest and multiple monetization paths as nationwide clearing advances.

Anterix Inc (ATEX) reports strong cash position and growing market recognition of its low-band spectrum, with active utility deals and satellite partnerships expanding monetization potential.

Anterix (NASDAQ:ATEX) said it is seeing accelerating interest in its licensed low-band spectrum portfolio as demand grows among utilities, wireless providers and satellite connectivity companies. The company also reported first-quarter fiscal 2027 revenue of $2 million, an approximately $11 million

ATEX posts 38.1% revenue growth in fiscal Q1 2027, while spectrum-clearing costs weighed on profit and advanced spectrum activity.

Moby summary of Anterix Inc.'s Q1 2027 earnings call

Anterix (ATEX) delivered earnings and revenue surprises of +3.64% and -0.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Camtek (CAMT) delivered earnings and revenue surprises of +2.63% and +2.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Anterix stock has had a very strong run over the past year, yet the valuation checks currently lean expensive rather than pointing to a clear bargain. For investors looking at Anterix today, the question is whether the recent share price strength lines up with the fundamentals that typically support a sustained valuation. Anterix has returned 369.8% over the past year, which puts extra focus on whether recent gains are already pricing in much of the good news. Strong operational momentum,...

Anterix (NASDAQ:ATEX) stockholders approved all five proposals presented at the company’s 2026 annual meeting, including the election of seven directors, an advisory vote on executive compensation and an amendment to the company’s 2023 Stock Plan. Executive Chairman Thomas Kuhn chaired the meeting,

ATEX's fiscal Q1 revenues might have risen on higher spectrum demand, supported by Lynk satellite tests and Benton County's private wireless deployment.

Anterix (ATEX) has surged 380% over the past year, recently hitting an all-time high of $113. ATEX maintains strong technical momentum with a 100% “Buy” rating from Barchart. Revenue is forecast to grow 220.2% this year and 33.7% next year, supporting continued bullish sentiment. Valuation concerns persist, with Seeking Alpha...

Bandwidth (BAND) delivered earnings and revenue surprises of +2.78% and +1.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made the biggest moves today.

Barclays raised Blue Bird’s price target to $85, adding that the group remains investable, while JPMorgan raised its price target on Anterix to $133 from $50 while maintaining an ‘Overweight’ rating.